DeFi
DeFi

Kalshi Pushes Deeper Into Crypto Derivatives With Bitcoin-Backed Margin Loans

Bitcoin Magazine Kalshi Pushes Deeper Into Crypto Derivatives With Bitcoin-Backed Margin Loans A new tri-party lending structure with BitGo lets…
Oct 21, 2026
DeFi

Crypto Long & Short: Why real-world assets need fixed-rate loans onchain

Real-world assets already back the largest stablecoins, yet borrowing against them onchain still runs through variable-rate pools. Peter Gaffney of…
Oct 21, 2026
DeFi

OCC’s Final Stablecoin Rule Backs Off Yield Test, Scraps Automatic Redemption Extension

The national bank regulator’s rule keeps a two-business-day redemption window, replaces an automatic seven-day extension with one issuers must request…
Oct 21, 2026
DeFi

Lido’s proposed exits would pay lenders with borrower collateral

Fallback Exits would reduce debt alongside collateral, while healthy-position eligibility and the lender’s route to ETH remain unsettled. Read the…
Oct 21, 2026
DeFi

OCC Finalizes GENIUS Act Rule, Drops Third-Party Yield Presumption

The rule takes effect Jan. 18, 2027, while existing issuers with substantially complete OCC applications pending can seek temporary compliance…
Oct 21, 2026
DeFi

PancakeSwap TVL tops $380M as major fee overhaul heads to vote

PancakeSwap’s proposed fee-sharing overhaul would give liquidity providers 88% of swap fees and cut CAKE emissions by 69%, as BNB…
Oct 21, 2026
DeFi

France proposes liability for crypto exchanges offering DeFi access

French authorities want crypto exchanges to conduct checks on DeFi protocols and face liability for certain customer losses under proposed…
Oct 21, 2026
DeFi

SpaceX Share Unlock Looms Over Aave Collateral Proposal

LlamaRisk recommends a 55% collateral factor and a 37,000-token cap, with larger liquidations dependent on redemptions or derivatives hedges. Read…
Oct 21, 2026
DeFi

SpaceX’s $194 billion share unlock exposes a major risk in Aave’s tokenized stock ambitions

About 1.3 billion SpaceX shares become eligible for sale on Oct. 22, worth roughly $194.3 billion at the Oct. 20…
Oct 21, 2026
AI

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off…
Oct 20, 2026